Treatment of insomnia in the context of neuropathic pain

Česká verzia

Authors: D. Kec ^1,2; J. Bednařík ^1,2; O. Ludka ^1,3,4; V. Hamerníková ⁵; E. Vlčková ^1,2
Authors place of work: LF MU Brno ¹; Neurologická klinika FN Brno ²; I. interní kardioangiologická klinika, FN u sv. Anny v Brně ³; Mezinárodní centrum klinického, výzkumu, FN u sv. Anny v Brně ⁴; Odborný psycholog, Brno ⁵
Published in the journal: Cesk Slov Neurol N 2019; 82(5): 513-517
Category: Přehledný referát
doi: https://doi.org/10.14735/amcsnn2019513

Summary

This summary explains the complex relationship between insomnia and neuropathic pain (NP) at both neurophysiological and psychological levels. It is focused on the possibilities of synergic action of the first line methods in therapy of insomnia and NP. In the first part we define basic terms such as „neuropathic pain“ and „insomnia“ and explain their mutual relationship between both clinical syndromes. The review focuses on the complex therapeutic approach covering both these clinical units. Attention is given to cognitive behavioral therapy (as the first treatment choice for chronic insomnia), and to pregabalin and gabapentin (both drugs being the first treatment choice for NP). Both of these therapeutic approaches are complementary: cognitive behavioral therapy has shown to have positive effects in NP treatment, while pregabalin and gabapentin proved to have potential of improving sleep.

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers.

Keywords:

psychotherapy – Neuropathic pain – chronic pain – Insomnia – sleep disorder – cognitive behavioral therapy – pregabalin – gabapentin

Zdroje

1. Fishbain DA, Cole B, Lewis JE et al. What is the evidence for chronic pain being etiologically associated with the DSM-IV category of sleep disorder due to a general medical condition? A structured evidence-based review. Pain Med 2010; 11(2): 158– 179. doi: 10.1111/ j.1526-4637.2009.00706.x

2. Biyik Z, Solak Y, Atalay H et al. Gabapentin versus pregabalin in improving sleep quality and depression in hemodialysis patients with peripheral neuropathy: a randomized prospective crossover trial. Internat UrolNephrol 2013; 45(3): 831– 837. doi: 10.1007/ s11255-012-0193-1.

3. Roth T, Arnold LM, Garcia-Borreguero D et al. Clinical review: a review of the effects of pregabalin on sleep disturbance across multiple clinical conditions. Sleep Med Rev 2014; 18(3): 241– 251. doi: 10.1016/ j.smrv.2013.07.005.

4. Senba E. A key to dissect the triad of insomnia, chronic pain, and depression. Neurosci Lett 2015; 589: 197– 199. doi: 10.1016/ j.neulet.2015.01.012.

5. Argoff CE. The coexistence of neuropathic pain, sleep, and psychiatric disorders: a novel treatment approach. Clin J Pain 2007; 23(1): 15– 22. doi: 10.1097/ 01.ajp.0000210945.27052.b3.

6. Stiefel F, Stagno D. Management of insomnia in patients with chronic pain conditions. CNS Drugs 2004; 18(5): 285– 296. doi: 10.2165/ 00023210-200418050-00002.

7. Riemann D, Baglioni C, Bassetti C et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res 2017; 26(6): 675– 700. doi: 10.1111/ jsr.12594.

8. Sateia MJ, Buysse DJ, Krystal AD et al. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 2017; 13(2): 307– 349. doi: 10.1378/ chest.14-0970.

9. Závěšická L. Pacient s nespavostí v ordinaci psychiatra. In: Příhodová I, Dostálová S (eds). Spánková medicína v kazuistikách. Praha: Mladá fronta 2016: 23– 35.

10. Šonka K, Espa-Červená K. Primární insomnie dospělých – b) terapie. In: Raboch J, Uhlíková P, Hellerová P et al (eds). Psychiatrie: Doporučené postupy psychiatrické péče IV. Praha: Typografia 2014: 150– 153.

11. Attal N, Cruccu G, Baron R et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17(9): 1113– 1188. doi: 10.1111/ j.1468-1331.2010.02999.x.

12. Treede R, Jensen T, Campbell J et al. Neuropathic pain – redefinition and a grading system for clinical and research purposes. Neurology 2008; 70(18): 1630– 1635. doi: 10.1212/ 01.wnl.0000282763.29778.59.

13. Neudertová H. Bolest jako syndrom. In: Hakl M (ed).Léčba bolesti: současné přístupy k léčbě bolesti a bolestivých syndromů. 2. vyd. Praha: Mladá fronta 2013: 27– 30.

14. American Academy of Sleep Medicine. The international classification of sleep disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine 2014.

15. Koh K, Hamada A, Hamada Y et al. Possible involvement of activated locus coeruleus– noradrenergic neurons in pain-related sleep disorders. Neurosci Lett 2015; 589: 200– 206. doi: 10.1016/ j.neulet.2014.12.002.

16. Vinik A, Emir B, Parsons B et al. Prediction of pregabalin-mediated pain response by severity of sleep disturbance in patients with painful diabetic neuropathy and post-herpetic neuralgia. Pain Med 2014; 15(4): 661– 670. doi: 10.1111/ pme.12310.

17. Druga R, Grim M, Dubový P. Anatomie centrálního nervového systému. In: Druga R (ed). Přehled drah centrálního nervového systému. 1. vyd. Praha: Galén-Karolinum 2011: 186– 219.

18. Čihák R. Funkční systémy centrálního nervového systému – nervové dráhy. In: Čihák R (ed). Anatomie 3. 2. vyd. Praha: Grada 2004: 413– 467.

19. Claustrat B, Brun J, Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev 2005; 9(1): 11– 24. doi: 10.1016/ j.smrv.2004.08.001.

20. Masters A, Pandi-Perumal SR, Seixas A et al. Melatonin, the hormone of darkness: from sleep promotion to ebola treatment. Brain Disord Ther 2014; 4(1): pii: 1000151. doi: 10.4172/ 2168-975X.1000151.

21. Holsboer-Trachsler E, Prieto R. Effects of pregabalin on sleep in generalized anxiety disorder. Int J Neuropsychopharmacol 2013; 16(4): 925– 936. doi: 10.1016/ j.smrv.2004.08.001.

22. Bjurstrom MF, Irwin MR. Polysomnographic characteristics in nonmalignant chronic pain populations: a review of controlled studies. Sleep Med Rev 2016; 26: 74– 86. doi: 10.1016/ j.smrv.2015.03.004.

23. Von Korff M, Vitiello MV, McCurry SM et al. Group interventions for co-morbid insomnia and osteoarthritis pain in primary care: the lifestyles cluster randomized trial design. Contemp Clin Trials 2012; 33(4): 759– 768. doi: 10.1016/ j.cct.2012.03.010.

24. Wu JQ, Appleman ER, Salazar RD et al. Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions: a meta-analysis. JAMA Intern Med 2015; 175(9): 1461– 1472. doi: 10.1001/ jamainternmed.2015.3006.

25. Tang NK, Goodchild CE, Salkovskis PM. Hybrid cognitive-behaviour therapy for individuals with insomnia and chronic pain: a pilot randomised controlled trial. Behav Res Ther 2012; 50(12): 814– 821. doi: 10.1016/ j.brat.2012.08.006.

26. Yoshino A, Okamoto Y, Doi M et al. Effectiveness of group cognitive behavioral therapy for somatoform pain disorder patients in Japan: a preliminary non-case-control study. Psychiatry Clin Neurosci 2015; 69(12): 763– 772. doi: 10.1111/ pcn.12330.

27. Neudertová H. Psychoterapie pacientů s chronickým algickým syndromem. In: Hakl M (ed). Léčba bolesti: současné přístupy k léčbě bolesti a bolestivých syndromů. 2. vyd. Praha: Mladá fronta 2013: 128– 134.

28. Smith MT, Perlis ML, Park A al et. Comparative meta--analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2002; 159(1): 5– 11. doi: 10.1176/ appi.ajp.159.1.5.

29. Bednařík J, Ambler Z, Keller O et al. Klinický standard pro farmakoterapii neuropatické bolesti. Cesk Slov Neurol N 2012; 75/ 108(1): 93– 101.

30. Smolík P, Pretl M, Konštacký S. Diagnostické a terapeutické postupy při insomniích pro praktické lékaře. Doporučený diagnostický a léčebný postup pro všeobecné praktické lékaře: novelizace 2011. 10. vyd. Praha: Společnost všeobecného lékařství ČLS JEP 2011.

31. Bazil C, Dave J, Cole J et al. Pregabalin increases slow-wave sleep and may improve attention in patients with partial epilepsy and insomnia. Epilepsy Behav 2012; 23(4): 422– 425. doi: 10.1016/ j.yebeh.2012.02.005.

32. Cho YW, Song ML. Effects of pregabalin in patients with hypnotic-dependent insomnia. J Clin Sleep Med 2014; 10(5): 545– 550. doi: 10.5664/ jcsm.3708.